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Abstract
Background: The intestinal mucosa displays robust virus replication and pronounced CD4+ T-cell loss during acute human
immunodeficiency virus type 1 (HIV-1) infection. The ability of HIV-specific CD8+ T-cells to modulate disease course has
prompted intensive study, yet the significance of virus-specific CD8+ T-cells in mucosal sites remains unclear.
Methods and Findings: We evaluated five distinct effector functions of HIVgag-specific CD8+ T-cells in rectal mucosa and
blood, individually and in combination, in relationship to clinical status and antiretroviral therapy (ART). In subjects not on
ART, the percentage of rectal Gag-specific CD8+ T-cells capable of 3, 4 or 5 simultaneous effector functions was significantly
related to blood CD4 count and inversely related to plasma viral load (PVL) (p,0.05). Polyfunctional rectal CD8+ T-cells
expressed higher levels of MIP-1b and CD107a on a per cell basis than mono- or bifunctional cells. The production of TNFa,
IFN-c, and CD107a by Gag-specific rectal CD8+ T-cells each correlated inversely (p,0.05) with PVL, and MIP-1b expression
revealed a similar trend. CD107a and IFN-c production were positively related to blood CD4 count (p,0.05), with MIP-1b
showing a similar trend. IL-2 production by rectal CD8+ T-cells was highly variable and generally low, and showed no
relationship to viral load or blood CD4 count.
Conclusions: The polyfunctionality of rectal Gag-specific CD8+ T-cells appears to be related to blood CD4 count and
inversely related to PVL. The extent to which these associations reflect causality remains to be determined; nevertheless, our
data suggest a potentially important role for mucosal T-cells in limiting virus replication during chronic infection.
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Introduction
A significant body of work has demonstrated the contribution of
HIV-specific CD8+ T-cell responses to immunological control of
HIV infection [1–3]. However, the relationship between cytotoxic
T-lymphocyte (CTL) response magnitude and clinical parameters
has proven controversial. Mathematical models based upon the
ability of CTL to clear virally infected cells predicted an inverse
relationship between blood CTL frequency and HIV plasma viral
load in the absence of antiretroviral therapy [4]. Some reports,
using MHC class I tetramers and/or Elispot assays to quantify
HIV-specific T-cell responses, did in fact reveal such an inverse
relationship [5,6]. However, subsequent studies did not produce a
consensus on this point: one study reported a positive correlation
between plasma viral load and the total HIV-specific, Env-, and
Nef-specific CD8+ T-cell frequency [7], while at least two others
found no numerical relationship [8,9]. Recently, additional light
has been shed on this issue by reports documenting a unique
relationship between the breadth and/or magnitude of Gag-
specific CD8+ T-cell responses (but not Env, Pol or Nef-specific
responses) and plasma viremia and/or blood CD4 count [10–16].
Mechanisms proposed to explain the immunodominance of Gag-
specific responses include early recognition of infected cells by
Gag-specific CTL [17] and immune pressures exerted by CTL
specific for conserved Gag functional domains [18].
Given the ambiguous relationship between HIV-specific T-cell
response magnitude and clinical parameters, investigators have
sought new combinations of immunological markers whose
expression might more reproducibly correlate with clinical status.
The advent of multiparameter flow cytometry, allowing the
simultaneous measurement of multiple effector molecules, has led
to an emphasis on T-cell response ‘‘quality’’ or ‘‘functional
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responses alone [19]. While it could be argued that the
measurement of five functions will not necessarily provide more
relevant information than the measurement of a single function,
recent findings have in fact demonstrated the added value of this
approach. HIV long-term nonprogressor status was associated
with the ability of HIV-specific CD4+ T-cells to produce both IL-2
and IFNc [20]. Conversely, in individuals with progressive disease,
HIV-specific CD4+ T-cell responses were skewed towards
production of IFNc in the absence of IL-2 [21]. In one study,
the ability to mount 4 and 5 functions simultaneously (i.e., IFNc,
TNFa, IL2, MIP-1b and CD107a) was a characteristic of HIV-
specific CD8+ T-cells in long-term nonprogressors [22]. In a
related study, the control of HIV-1 replication in HLA-B27
subjects was associated with the ability of B27-KK10-specific
CD8+ T-cells to mount multiple effector functions [23]. T-cell
responses associated with successful vaccines also support the
clinical relevance of polyfunctionality. Humans immunized with
vaccinia virus generate polyfunctional virus-specific CD8+ T-cells
[24], and vaccine-induced protection of mice challenged with
Leishmania major is accompanied by T-helper type 1 cells that are
able to produce multiple cytokines [25].
Most prior studies of HIV-specific cell-mediated immunity have
assessed responses only in the peripheral blood compartment; little
information is available concerning HIV-specific T-cell responses in
mucosal tissues. In a previous study focused primarily on IFN-c
production, we reported that rectal CD8+ T-cell responses to Gag
wereimmunodominant (as compared to Pol and Env) in chronically
infected subjects not on antiretroviral therapy with a broad range of
viral loads [26]. We also found that the production of IFN-c by
rectal HIV-gag CD8+ T-cells was positively associated with blood
CD4 count during chronic infection [26], and began to explore the
ability of rectal CD8+ T-cells to mount multiple effector responses,
including CD107a, TNF-a and IFN-c. In the present study, we
have extended these analyses to include five effector functions, both
individually and combination, building upon our existing cohort of
individuals with chronic HIV infection.
In the present work, we have analyzed paired blood and rectal
biopsies from chronically infected patients for five distinct
responses to HIVgag stimulation: production of the cytokines
IFN-c, IL-2, TNF-a, the chemokine MIP-1b, and the cytolytic
granule constituent CD107a, which is an indirect marker for
cytotoxic potential [27]. We present a detailed analysis of the
relationship between each individual effector function and clinical
parameters, as well as the relationship between T-cell polyfunc-
tionality and clinical parameters. The patient group includes 15
individuals not on antiretroviral therapy (ART) with viral loads
ranging from ,50 to .50,000 copies/ml, as well as 13 patients on
ART for at least one year. We also introduce a new statistics-based
approach to determining when an antigen-specific response is
significantly different from background; the aim of this tool is to
remove potential bias and facilitate data interpretation in instances
when cell number is variable and background high, as is frequently
the case with mucosal samples.
Using an expanded panel of response parameters coupled with
a new and rigorous statistical approach to evaluating when a
response is significant (see Materials & Methods), here we report
on multiple significant associations between CD8+ T-cell respons-
es in rectal mucosa and both plasma viral load and blood CD4
count. Such associations were not evident when evaluating
peripheral blood CD8 responses in relationship to plasma viral
load or blood CD4 count in the same patients. We also report that
HIV-specific CD8+ T-cell responses in rectal mucosa of patients
on long-term suppressive ART are characterized by low
magnitude and a marked qualitative shift towards monofunctional
responses when compared to patients not on ART. Thus, rectal
mucosal CD8+ T-cells are not only capable of potent and
diversified effector responses, but these responses bear a
relationship to clinical status during chronic HIV infection.
Results
Characteristics of Study Subjects
Plasma viral load, blood CD4 count, and other clinical
information for the 36 study participants are shown in Table 1.
Study participants included 15 seropositive individuals not on
ART, 13 seropositive subjects on ART, and 8 seronegative
volunteers. Several of these patients participated in an earlier study
of mucosal T-cell responses [26]; however, fresh biopsy samples
were obtained for the present work. For seropositive subjects, the
number of years since initial HIV-1 seropositivity ranged from 1 to
25 years. Time since seroconversion averaged 8.3 years for
patients not on ART and 10.7 years for patient on ART, a
difference which was not statistically significant (Mann Whitney
test, 2-tailed, p.0.05). The subject pool was primarily Caucasian
(56%) and African American (33%), and the gender distribution
was approximately two-thirds male and one-third female. Among
seropositive subjects not on ART, viral loads ranged from ,50 to
89,700 copies per ml plasma, and blood CD4 counts ranged from
304 to 883 cells per ml blood (Table 1). Among the 13 subjects on
ART, the time since ART initiation ranged from 1–15 years; drug
combinations at the time of biopsy are given in Table 1. Three of
the 13 subjects on ART did not have fully suppressed plasma
viremia. Seronegative subjects were confirmed to be uninfected by
HIV-1 antibody testing and plasma viral load testing.
Flow cytometry gating
The gating strategy used to analyze data from the ICS assay of a
typical rectal MNC sample stimulated with HIVgag peptides plus
costimulatory antibodies is illustrated in Figure 1. A lymphocyte
gate based on forward/side scatter was followed by a viability gate
(7-AAD negative) and selection of cells positive for both CD3 and
CD8. These cells were further subdivided into individual
populations consisting of cells positive for MIP-1b, IFN-c TNF-
a, IL-2, and CD107a. Values from these populations were either
analyzed directly or the populations further subdivided into 31
possible combinations of functions [22,28]. In either case, values
were background-corrected as described in Materials and
Methods, using values from cells treated with costimulatory
antibodies alone. For phenotyping of rectal and peripheral
CD8+ T-cells, unstimulated cells underwent the same gating
strategy except that the CD3+CD8+ population was further
divided based upon expression of phenotypic markers rather than
response markers.
Rectal CD4+ T-cell percentages reflect peripheral blood
CD4 percentages in the group on ART
The dynamics of CD4+ T-cell restoration in mucosal tissues
following initiation of ART is an area of current interest [29,30].
We therefore measured CD4+ T-cells as a percentage of CD3+ T-
cells and explored the relationship between CD4+ T-cell
frequencies in rectal mucosa and blood in a cross-sectional
analysis of subjects either on or off ART, as shown in Fig. 2. CD4+
T-cell levels in both rectal mucosa and PBMC were lower in HIV-
infected individuals, irrespective of ART status, compared to
seronegative controls (Fig 2A). Although rectal CD4+ T-cell
percentages were frequently lower than blood CD4+ T-cell
percentages in patients not on ART, a comparison of CD4+ T-
Rectal CD8 Cells and HIV
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groups, using paired T-tests, did not reveal significant differences
between tissues. Of note, the group on ART had a higher median
rectal CD4+ T-cell frequency (39.6%) compared to the group not
on ART (28.0%), though this difference was not statistically
significant. Moreover, the group on ART displayed a significant
positive correlation between rectal and peripheral CD4 percent-
ages (Fig. 2B, p=0.001), while the group not on ART failed to
show such a relationship (Fig. 2C). The group on ART also
displayed an inverse correlation (p,0.05) between rectal CD4
percentage and plasma viral load (data not shown).
Rectal CD8+ responses are robust compared to PBMC,
but are strongly attenuated by ART
All Gag-specific responses reported in this study were first
evaluated for significance, in relation to responses associated with
exposure to costimulatory antibodies alone, using a statistical test
Table 1. Patient Characteristics.
Patient
ID
a Gender
b Ethni-city
c
HLA Class I
Genotype
Blood CD4
(cells/mm
3)
Plasma VL (RNA
copies/ml)
Yrs
HIV
+
ART (at time
of biopsy)
d
ART Duration
(minimum time)
6 M AA A2/A74/B49/B81 367 1,130 17 No NA
32 F H A3/A11/B7/B27 740 5,370 11 No NA
50 F AA A30/B8/B27 619 281 18 No NA
56 M C A1/A29/B8/B44 304 76,000 3 No NA
58 M C A1/A2/B51/B58 538 89,700 7 No NA
60 M C A2/A3/B14/B39 669 703 25 No NA
62 F C A1/A2/B37/B57 571 12,700 5 No NA
65 M C A1/A2/B7/B8 719 63,800 1 No NA
66 M C A23/A68/B8/B51 481 83,900 1 No NA
67 M C A11/A24/B13/B52 715 27,100 1 No NA
71 M H A11/A31/B15/B51 463 34,900 9 No NA
78 M H A2/A68/B18/B57 636 109 1 No NA
79 F C A2/A30/B14/B52 553 7,170 11 No NA
85 M C A1/A68/B27/B57 883 ,50 10 No NA
98 F C A2/A25/B8/B18 608 69,600 4 No NA
51 F AA A30/A68/B45 358 11,000 12 FTC+TDF+EFV 10 yr
54 T C A24/A68/B51 512 ,50 17 EFV+3TC+TDF 1 yr
57 M C A1/B7/B8 442 ,50 7 AZT+3TC+EFV 4 yr
63 F C A1/A2/B8/B44 464 ,50 4 TDF+EFV+ABC+AZT 4 yr
64 M C A11/A24/B7/B44 851 ,50 24 ABC+3TC+ATV+RTV 15 yr
77 M AA A2/A33/B53/B57 408 ,50 17 FTC+TDF+RTV+ATV 3 yr
80 M C A2/A31/B44/B51 927 ,50 17 FTC+TDF+RTV+ATV 3 yr
81 M AA A68/B7/B58 527 557 6 DDI+TDF+RTV+FPV 4 yr
83 M AA A23/A74/B15/B18 287 ,50 1 DDI+TDF+LPV+RTV 2 yr
88 M C A2/A29/B14/B49 316 ,50 6 AZT+3TC+EFV 4 yr
89 I AA A3/B7/B49 434 7,660 6 ABC+3TC+ATV 2 yr
92 M C A2/A26/B40/B44 545 ,50 19 FTC+TDF+LPV+RTV 6 yr
93 F C A1/B8/B39 809 ,50 3 3TC+TDF+RTV+ATV 3 yr
27 M AA A23/A24/B15/B27 837 ,50 NA HIV neg NA
74 M AA A30/A68/B15/B57 322 ,50 NA HIV neg NA
86 F AA A23/B18/B49 670 ,50 NA HIV neg NA
87 F C A2/A24/B7/B57 742 ,50 NA HIV neg NA
91 F C A2/B8/B35 714 ,50 NA HIV neg NA
94 F As A11/A33/B44/51 228 ,50 NA HIV neg NA
96 M AA ND 1396 ,50 NA HIV neg NA
100 M AA A1/A30/B44/B49 609 ,50 NA HIV neg NA
aID, identification number.
bM, male; F, female; T, transgender; I, intersex.
cAA, African-American; As, Asian; C, Caucasian; H, Hispanic.
dABC, Abacavir; ATV, Atazanavir; AZT, Azidothymidine; DDI, Didanosine; EFZ, Efavirenz; FPV, Fosamprenavir; FTC, Emtricitabine; LPV, Lopinavir; RTV, Ritonavir; TDF,
Tenofovir Disoproxil Fumarate; 3TC, Lamivudine.
doi:10.1371/journal.pone.0003577.t001
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Responses to HIVgag peptide stimulation (i.e., percentages of
responding CD8+ T-cells) were first analyzed individually, as
summarized in Figure 3. For CD107a, IFN-c, MIP-1b, and TNF-a,
responses were vigorous in both tissue compartments in patients not
on ART. IL-2 production by CD8+ T-cells was weak or absent in
most subjects and in both tissues. In the subject group not on ART,
rectal responses were particularly robust compared to blood; for
CD107a and IFN-c the differences between median response
magnitudes when comparing rectal mucosa to blood were greater
than 2-fold and were statistically significant. As predicted, mucosal
T-cell responses in patients on ART were lower in magnitude than
in the untreated group. Furthermore, the difference in response
magnitude in rectal mucosa between patients off and on ART was
statistically significant for three functions: CD107a, IFN-c,a n d
MIP-1b (Figure 3). Although response magnitudes in PBMC
showed a similar trend, only one function, MIP-1b production,
showed a significant difference when comparing the two treatment
groups. Thus, ART was associated with a particularly striking
decrease in the magnitude of HIV-specific T-cell effector functions
in rectal mucosa.
Rectal but not peripheral CD8+ T-cell response
magnitudes in subjects not on ART correlate with plasma
viral load and blood CD4 count
As shown in Fig. 3, the group of subjects not on ART displayed
a broad range of response magnitudes in both rectal mucosa and
blood for each individual function, with the exception of IL-2. For
example, net rectal CD107a response values ranged from zero to
10.4%. To investigate whether response magnitudes were related
to virus replication or clinical status, we looked for correlations
with plasma viral load and blood CD4 count (Fig. 4). Strikingly, in
rectal mucosa, three of the five Gag-specific CD8+ T-cell
responses measured (i.e., CD107a, IFN-c, and TNF-a) were
found to be inversely correlated with plasma viral load (p,0.05).
Furthermore, CD107a and IFN-c responses in rectal mucosa were
positively correlated with blood CD4 count (p,0.05). In contrast,
Gag-specific response magnitudes in PBMC were not significantly
related to viral load or to blood CD4, and rectal CD8+ T-cell
responses did not show a significant relationship to rectal CD4
percentage (data not shown). These findings suggest that, in
individuals with chronic infection in the absence of ART, HIV-
specific T-cell responses measured in rectal mucosa may be a
stronger correlate of viral replication and immune status than the
corresponding responses measured in peripheral blood.
CD8+ T-cells in rectal mucosa display complex
functionality which is diminished with ART
In the subject group not on ART, the enhanced HIVgag
responsiveness of rectal CD8+ T-cells in comparison to PBMC,
and the significant relationship of rectal responses with plasma
viral load and blood CD4 count (Fig. 4), led us to ask whether the
ability of rectal CD8+ T-cells to mount complex polyfunctional
responses might also be related to clinical parameters. To analyze
response complexity, we subjected the antigen-specific response
data (derived as shown in Fig. 1) to Boolean gating analysis,
generating 31 separate response categories consisting of all possible
combinations of functions. The results from this analysis,
generated using SPICE software, are illustrated in Fig. 5. In
agreement with previous reports [22], this analysis resulted in the
distribution of cells into a small number of distinct response
groups. The most complex group, which was observed at low
frequency, was that displaying all 5 functions. Other major groups,
shown from left to right in Fig. 5B, were the 4+ group (lacking IL-
Figure 1. Flow cytometry gating method used in the analysis of CD8+ T-cell responses. Shown is a typical rectal mucosal cell preparation
that was stimulated with HIVgag peptides. After initial estimation of a lymphocyte gate based on forward versus side scatter, viable cells (7-AAD
negative) were carried forward for selection of CD3+CD8+ cells. The resulting CD3+CD8+ population was further gated based on positivity for each of
the 5 functional responses measured: MIP-1b, TNF-a, IFN-c, IL-2 and CD107a. The frequencies of cells in these populations were corrected using
background values (costimulation only) and then compiled and analyzed directly. For more detailed analyses, the 5 populations were instead entered
into Boolean gating analysis to generate 31 populations consisting of all possible combinations of functionality (the 32
nd population representing
cells negative for all 5 functions was ignored). Background correction was applied after Boolean gating (see Methods).
doi:10.1371/journal.pone.0003577.g001
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predominant 2+ group (expressing only CD107a and MIP-1b),
and the predominant 1+ group expressing only MIP-1b.
The mean total percentage of rectal CD8+ T-cells responding to
HIVgag stimulation in any way (i.e., all 31 non-overlapping
categories combined) was 5.9% for the group not on ART. The
pie charts and bar graphs provide finer details illustrating that
nearly one-half of the rectal response in patients not on ART was
comprised of polyfunctional cells capable of 3, 4, or 5 responses
simultaneously. In contrast, in the group on ART, the mean
percentage of rectal CD8+ T-cells responding to HIVgag
stimulation was 2.9%. Even more strikingly, cells producing 3, 4,
or 5 responses accounted for less than 10% of the responding
population, as shown in the pie chart. Thus, in this cross-sectional
comparison of patients on and off ART, ART was associated with
a striking absence of polyfunctionality in rectal mucosa.
In PBMC of patients not on ART, the mean percentage of
HIVgag-specific CD8+ T-cells was lower than in rectal mucosa
(3.8% vs. 5.9%), and approximately 30% of this response was
derived from cellscapable of at least 3 responses. In the ART group,
the mean percentage of responding cells was 1.1%, fewer than 20%
of which were polyfunctional. Figure 5B is a graphical representa-
tion of the results of linear mixed model analysis for the data shown
in Figure 5A. Data for each tissue and patient group are
summarized by individual bars, and letter codes are used to identify
statistically significant differences between groups. Polyfunctional
cells, capable of 3, 4 or 5 functions, are represented by open bars,
and cells capable of only 1 or 2 functions are represented by filled
bars. As shown in the figure, HIVgag-specific responses in patients
on ART showed reduced magnitude and complexity as compared
to responses in patients not on ART. Notably, CD8+ T-cell
response complexity wasfar more sensitive to ARTinrectalmucosa
than in PBMC in this cross-sectional data set.
Response complexity is related to blood CD4 count and
plasma viral load
The utility of Boolean gating analysis lies not only in the ability
to assemble a detailed view of responding CD8+ T-cell
populations (Fig. 5), but also in the opportunity to look within
selected response categories for relationships between responses
and clinical status. We therefore asked whether any single response
category in blood or rectal mucosa, or combination of categories,
was significantly related to blood CD4 count or plasma VL. These
analyses were limited to those T-cell response categories for which
at least 50% of the responses were greater than zero, and the
analysis of subjects was limited to those not on ART, since those
on ART had a high percentage of zero values.
Rectal, but not peripheral, Gag-specific CD8+ T-cell responses
within certain functional categories showed significant correlations
with clinical status. The strongest of these relationships was
observed when the percent response was summed across the three
predominant polyfunctional categories and the summed values
were plotted against blood CD4 count or plasma viral load.
Figure 6 shows results of this analysis; the total of 3+,4 +, and 5+
CD8+ T-cell frequencies was positively correlated with blood CD4
count (r=0.621, p=.024) and negatively correlated with plasma
viral load (r=20.636, p=.026). In contrast, the summed 1- and 2-
function responses showed no relationship to blood CD4 or
plasma viral load (not shown). Additional significant correlations
(p,.05) included mucosal 4 and 3-function CD8 responses in
relation to blood CD4 count; mucosal 4-function CD8 responses
in relation to plasma viral load; and the summed 1+ through 5+
mucosal Gag-specific CD8 response in relation to blood CD4
count and plasma viral load (data not shown). Although similar
Figure 2. CD4+ T-cell percentages in rectal mucosa and
peripheral blood. (A) CD4 values for rectal mucosa and peripheral
blood are indicated as a percentage of CD3+ cells for subjects on and
off ART, and seronegative subjects. The horizontal line denotes the
median. Statistically significant differences (p,0.05) within each tissue
are denoted by a line with asterisk. SN, seronegative. (B & C) Correlation
analysis (Spearman) of CD4+ T-cell percentages from each tissue for
patients on ART (Part B, filled triangles) and not on ART (Part C, filled
circles). Lines represent best fits as estimated by linear regression.
doi:10.1371/journal.pone.0003577.g002
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responses, we did not identify any significant relationships between
total blood CD8 responses or any subset of blood CD8 responses
and either plasma VL or blood CD4 count (not shown). In
addition, functionality of rectal CD8+ T-cell responses failed to
exhibit any significant correlation with rectal CD4 frequency as a
percent of CD3+ T-cells (not shown).
The production of MIP-1b and CD107a on a per-cell basis
intensifies as cell functionality increases
Polyfunctional CD8+ T-cells have previously been demonstrat-
ed to produce more IFN-c on a per-cell basis than cells of lower
functionality [23–25]. In the present data set, the expression of
MIP-1b and CD107a were highly conserved across the predom-
inant response categories for subjects not on ART (Fig. 5). This
pattern of conserved expression afforded the opportunity to
evaluate the median fluorescence intensity (MFI) of these factors
across the spectrum from single-positive to 5-function positive cells
in both PBMC and rectal mucosa. MFI values were adjusted by
subtracting the MFI of cells negative for expression. As shown in
Figure 7, MIP-1b and CD107a MFIs in rectal CD8+ T-cells
(Figs. 7A & 7B) were significantly increased at higher levels of
response complexity compared to single positive cells. In
peripheral blood (Figs. 7C & 7D), MIP-1b showed the same
pattern as in rectal mucosa, while CD107a MFI showed no
changes across the response categories.
The expression of activation markers and perforin and
granzyme on CD8+ T-cells reveals tissue and ART-
dependent effects
Typical lymphocyte activation markers were generally ex-
pressed at higher levels by CD8+ T-cells in rectum than in PBMC
(Fig. 8). In agreement with earlier studies [31], the early activation
marker CD69 was highly expressed on rectal CD8+ T-cells as
compared to PBMC. This high level of expression, approximately
75%, was unaffected by ART and was equally high in the
seronegative group. The expression of CD25 was lower in
magnitude but similar in expression pattern to that of CD69; this
marker was more highly expressed in rectal CD8+ T-cells
generally than in PBMC, irrespective of ART or serological
status. The activation marker HLA-DR was more strongly
expressed in rectal mucosa than PBMC of all three groups, and
showed a trend towards higher expression in rectal mucosa of
seropositive patients not on ART as compared to other groups.
As previously reported, perforin expression was extremely low
in rectal CD8+ T-cells as compared to PBMC [32]; however,
three untreated HIV positive patients in this study expressed
perforin in .20% of rectal CD8+ T-cells. Granzyme B expression
in rectal mucosa CD8+ T-cells of seropositive individuals not on
therapy was significantly elevated compared to both subjects on
ART and seronegative subjects. This pattern was also evident in
PBMC, though in this compartment the effect of ART was not
statistically significant.
Discussion
In this study we introduce the use of a statistical approach to
establish when an antigen-specific response is significantly different
from the response elicited by costimulatory antibodies alone (see
Materials & Methods). While this issue may seem mundane, it is in
fact critically important when small populations of responding cells
are distributed amongst 31 Boolean combinations, a process that
can result in categories containing relatively few events (i.e.,
individual cells), as is frequently the case for samples derived from
tissue biopsies [33]. Further, baseline cytokine production in rectal
mucosa is generally higher than in PBMC [26,34,35]; this higher
background is another reason to apply greater rigor in
determining the significance of antigen-specific responses. The
method we present here takes into account the absolute numbers
of responding cells in a given sample, as well as the total number of
cells analyzed. This permits a statistical evaluation on a category-
by-category basis of whether an antigen-specific response is
significantly different from background. Accordingly, this ap-
proach may prove useful for future studies of mucosal immune
responses, including for vaccine trials.
Virions in circulation are thought to originate from tissue sites of
active virus replication. As the intestinal tract is a major lymphoid
organ that supports high levels of virus replication during acute
infection, it may also serve as a significant source of viremia during
chronic infection. In a previous study of a more limited patient
group, we observed that plasma viremia was inversely, though not
significantly, associated with IFNc production by Gag-specific
rectal CD8+ T-cells, while blood CD4 count showed a significant
positive correlation with Gag-specific rectal responses [26]. Here,
by expanding our focus to include additional patients as well as
five individual Gag-specific effector responses, we found that three
(CD107a, IFNc, and TNFa) of the five rectal responses were
inversely correlated with plasma viral load (p,.05), and two
(CD107a and IFNc) were positively correlated with blood CD4
Figure 3. Individual responses to HIVgag peptides mounted by rectal mucosal and peripheral CD8+ T-cells. Following peptide
stimulation, cells were evaluated for five distinct functions (i.e., production of IFN-c, TNF-a, IL-2, MIP-1b and CD107a) using flow cytometry. Values
shown are the percentage of CD8+ T-cells positive for a given function, with medians indicated by a horizontal line. Statistically significant differences
between groups (p,0.05) are denoted by a line with an asterisk. RM, rectal mucosa, PB, peripheral blood, ‘2’, not on ART; ‘+’, on ART.
doi:10.1371/journal.pone.0003577.g003
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terms of polyfunctionality, as defined by the ability to mount 3, 4,
or 5 responses simultaneously, significant relationships were also
evident between rectal Gag-specific responses and both plasma
viral load and blood CD4 count. Thus, our general finding is that
greater responsiveness of rectal gag-specific CD8+ T-cells, but not
peripheral blood CD8+ T-cells, is associated with lower plasma
viral load and elevated blood CD4 count. Determination of
whether the relationships between rectal antiviral responses and
peripheral viral load are causal will require additional study. The
degree to which rectal CD8 cells are responsible for limiting
mucosal virus production remains unknown and awaits intensive
analysis of tissue viral loads. It is also possible that mucosal CD8
responses are highest and most polyfunctional in individuals with
low viremia due to a comparatively intact immune system and the
availability of abundant CD4 help.
Others have observed that peripheral Gag-specific CD8+ T-cell
responses have clinical relevance as suggested by high-magnitude
Figure 4. Correlation (Spearman) of rectal CD8+ T-cell responses to plasma viral load or blood CD4 count in patients not on ART.
CD8+ T-cell responses (shown as percentages of cells producing cytokines/chemokines or CD107a, as in Fig. 3), were plotted against viral load and
CD4 percentages. Results for Spearman r value and level of significance are shown. Lines represent best fits as estimated by linear regression.
Comparable relationships between PBMC functional responses and clinical parameters are not shown, as none were statistically significant.
doi:10.1371/journal.pone.0003577.g004
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PLoS ONE | www.plosone.org 7 October 2008 | Volume 3 | Issue 10 | e3577Figure 5. Detailed HIVgag response profile for CD8+ T-cells in rectal mucosa and blood. (A) Response profiles were generated using
Boolean analysis of 5 functional response gates, resulting in 31 separate categories as described in the text. The percentage value shown in the center
of each pie diagram denotes the total magnitude of CD8+ T-cells responding in any way (i.e., a summation across all 31 categories). Individual color-
coded pie slices represent the fraction of cells within the total responding population displaying 5, 4, 3, 2, or 1 function(s), beginning at ‘12 o-clock’
and moving clock-wise, as compiled from the bar graph data. The bar graph provides fine detail on frequencies within each of the individual 31
categories; interquartile ranges and medians are shown. (B) Results from linear mixed model analysis of HIVgag-specific responses. ART status, tissue
type, and polyfunctionality were treated as fixed effects (see Methods). Polyfunctional cells (open bars) were defined as cells positive for 3, 4, or 5
functions, and non-polyfunctional cells (closed bars) were defined as cells positive for 1 or 2 functions. Letters are statistical notations; bars that do
not share a common letter are significantly different (p,0.05).
doi:10.1371/journal.pone.0003577.g005
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well as the ability of Gag-specific CTL to target conserved epitopes
in critical Gag functional domains, driving the introduction of
CTL escape mutations [18,37]. In addition, several recent reports
have revisited the relationship between peripheral Gag-specific
CD8+ T-cell responses and clinical parameters in clade B and C-
infected cohorts from North and South America as well as Africa
[10–16]. Considering these findings and our own, there is
emerging support for an association between Gag-specific CD8+
T-cell response magnitude and/or breadth, and clinical param-
eters such as viral load and blood CD4 count. The significant
correlations we identify in the current study, using a relatively
small cohort, suggest that HIV-specific CD8+ T-cell activity in
intestinal mucosal tissue may be more closely linked to clinical
status than CTL activity in peripheral blood alone.
Our finding of enhanced production of MIP-1b and CD107a
on a per-cell basis as functionality increases is the first observation
of this kind for mucosal CD8+ T-cells yet is consistent with other
studies reporting increased IFN-c production by polyfunctional T-
cells in peripheral blood [23–25]. Thus, our data lend additional
support to the idea that polyfunctional CD8+ T-cells not only
engage a greater number of effector functions but also implement
them to a higher magnitude. An example of the potential
relevance of this is that in the case of HIV infection, MIP-1b
production can play a dual role in host defense by blocking HIV
infection of prospective target cells and by recruiting CCR5-
bearing memory CD8+ T-cells to sites of infection. This dual role
may be of particular importance in the mucosal lamina propria,
where CD4+ T-cells are rapidly infected during acute infection. It
is also noteworthy that MIP-1b and CD107a were the two most
highly conserved responses in both rectal mucosa and peripheral
blood (Figs 3 & 5A), suggesting that these effector functions play
fundamentally important roles in the antiviral repertoire.
It has been known for some time that the magnitude of HIV-
specific CD8+ T-cell responses in peripheral blood declines rapidly
when individuals begin ART [38]. In contrast, very little
information is available on the effects of ART on peripheral
CTL response quality, or on mucosal CTL functionality overall.
Our data reveal that ART is associated with a reduced total
response magnitude in both blood and mucosa, as expected based
on previous studies, but the complexity of the response is affected
differentially in the two tissues (Fig 5A & B). In blood, the response
complexity was not different relative to ART status, an
observation which is consistent with a recent report [39]. In
contrast, the drastic reduction in rectal response complexity
associated with ART is a unique observation and suggests that
ART exerts more complex effects on mucosal CTL functionality.
Longitudinal studies of individuals on ART will be more revealing
and are underway in our laboratory; findings from these studies
will be presented elsewhere.
Immune reconstitution in the context of ART, particularly as
defined by CD4 repopulation in the intestinal tract and peripheral
blood, is of intense current interest. Previously we reported a
significant positive correlation between CD4 percentages in these
two compartments [26]; here, we discriminate between subject
groups and find that only the group on ART shows a significant
correlation between values in the two tissues. It is possible that this
relationship develops out of ART-induced reconstitution of CD4+
T-cells in peripheral blood and/or the intestine, though the cross-
sectional design of this study did not allow direct evaluation of
CD4 reconstitution. Our analysis of eight seronegative individuals
showed no correlation between peripheral and rectal mucosal
CD4+ T-cell percentages, with values for both tissues being much
more tightly clustered than in infected subjects.
In summary, we have shown here that rectal HIVgag-specific
CD8+ T-cells from chronically infected subjects not on ART are
able to mount robust and diverse effector responses which correlate
positively with blood CD4 count and inversely with plasma viral
load. These associations were not evident for peripheral blood
CD8+ T-cells, suggesting a unique status for mucosal HIV-specific
CD8+ T-cells which remains to be fully defined. In the context of
ART, a predictable drop in the total responding CD8+ T-cells in
both tissues was accompanied by a marked loss of response
complexity in rectal mucosa. The provision of ART was also linked
to the observation that peripheral and rectal CD4+ T-cell
percentages are tightly positively correlated.
Although a role for mucosal T-cell responses in limiting viral
dissemination during early/acute infection has been postulated,
the contribution of mucosal effector cells to the immune control of
viral replication during chronic infection has not been addressed.
The results presented here suggest that, when individuals
throughout a broad range of viral loads and blood CD4 counts
are evaluated, there are significant relationships between antiviral
mucosal effector responses (both individually and in combination),
Figure 6. Correlation (Spearman) of polyfunctional rectal CD8+
T-cell responses and plasma viral load or blood CD4 count.
Polyfunctionality was defined as the summed frequencies of the 5+ and
predominant 4+ &3 + groups (as shown in the bar graph, Fig. 4). This
derived value was plotted (X-axis) against blood CD4 count or plasma
viral load (Y-axis). Results for r and level of significance are shown.
Comparable relationships between PBMC polyfunctional responses and
clinical parameters are not shown, as they were not statistically
significant.
doi:10.1371/journal.pone.0003577.g006
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between mucosal CD8+ T-cells and clinical status cannot be
definitively established due to the cross-sectional nature of this
study; indeed, it is possible that polyfunctional responses are a
consequence of an intact immune system in individuals with low
viral replication, rather than the cause of low virus replication.
Additional studies will be required to address the relationship
between mucosal T-cell responses and tissue viral loads.
Materials and Methods
Study participants, clinical procedures, and tissue
processing
Subjects were chronically HIV-infected patients and seroneg-
ative volunteers and at the Center for AIDS Research, Education
and Services (CARES), Sacramento, CA. Patients taking and not
taking antiretroviral drugs were enrolled in the study. This patient
cohort has been described previously [26]; however, the tissue
samples and the analytical results presented for this study are
entirely new and have not been previously reported. Written
informed consent for phlebotomy and rectal biopsy was obtained
through study protocols approved by the Institutional Review
Board, School of Medicine, University of California, Davis. Blood
was collected by sterile venipuncture using EDTA as an
anticoagulant. Twenty-four rectal biopsies were taken endoscop-
ically approximately 10–15 cm from the anal verge as previously
described [26]. Tissue pieces were collected and immediately
placed in complete media (described below). Rectal biopsies and
blood were collected at the same visit to the clinic and processed
the day of collection.
PBMC were isolated from blood using Ficoll-Paque
TM (Pfizer-
Pharmacia, New York, NY). Isolation of mononuclear cells from
rectal biopsies was done using an optimized collagenase digestion
procedure as previously described [26,40]. Following isolation,
PBMC and rectal mononuclear cells (RMC) were incubated
overnight in complete medium [RPMI-1640 supplemented with
fetal calf serum (15%), penicillin (100 U/ml), streptomycin
(100 mg/ml), and glutamine (2 mM)]. Rectal cells were further
treated with Piperacillin-Tazobactam (0.5 mg/ml) (ZosynH, Wyeth
Pharmaceuticals, Philadelphia, PA) to inhibit overgrowth of
intestinal bacteria that may be present in rectal cell preparations.
Flow cytometry, blood CD4 and plasma viral loads
Flow cytometry data were acquired on an LSRII (BD
Immunocytometry Systems, San Jose, CA) equipped with 405,
488, and 643 nm lasers and utilizing FACSDIVA software (BDIS).
Analysis of cytometry data was done with FlowJo software (Tree
Star, Ashland, OR); for experiments measuring five functional
responses, individual cytokine gates were evaluated alone and also
processed through Boolean combinations to partition responding
cells into one of 31 possible specific response categories. Cytometry
data were biexponentially transformed inorder toinclude all events.
SPICE software (Mario Roederer, Vaccine Research Center,
NIAID/NIH, Bethesda, MD) was used to graph response data.
Blood CD4 count was determined by the clinical laboratory at
University of California, Davis, Medical Center. Plasma viral load
was measured by the California Department of Health Services,
Viral and Rickettsial Disease Laboratory using the Roche COBAS
HIV-1 Monitor v1.5 test. This method has a sensitivity cutoff of 50
HIV-1 RNA copies per ml plasma.
Figure 7. Median fluorescence intensity (MFI) of MIP-1b and CD107a staining of HIVgag specific CD8+ T-cells in relation to response
category. (A & B) Rectal mucosa. (C & D) Peripheral blood. Statistically significant differences (p,0.05) are denoted by a line with an asterisk.
doi:10.1371/journal.pone.0003577.g007
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Fluorochrome-labeled monoclonal antibodies to CD3 (clone
UCHT1), CD107a (clone H4A3), IFNc (clone B27), TNF-a (clone
MAb11), IL-2 (clone 6344.111), MIP-1b (clone D21-1351),
Granzyme B (clone GB11), and CD25 (clone M-A251) were
purchased from Pharmingen (San Diego, CA), as were unlabeled
CD28 (clone L293) and CD49d (clone L25), and 7-Amino-
Actinomycin D (7-AAD). Fluorochrome-labeled aniti-CD8 (clone
3B5), CD4 (clone S3.5), HLA-DR (clone TU36), and CD69 (clone
CH/4) were purchased from Invitrogen. Anti-CD4 (clone
SFCI12T4D11) was obtained from Beckman Coulter (Fullerton,
CA) and anti-Human Perforin (clone PF-164) was obtained from
MABTECH. The HIVgag peptide pool (p55, HXB2 sequence)
consisted of 15-mers with an 11 amino acid overlap (BD
Biosciences, San Jose, CA).
Intracellular cytokine staining (ICS), T-cell phenotyping,
and Flow cytometry
ICS assays and phenotypic staining were carried out on freshly
isolated PBMC and RMC that were rested overnight at 37uC, 5%
CO2 prior to analysis. For ICS, cells were stimulated with pooled
HIVgag peptides (3.5 mg/ml) plus costimulatory antibodies (CD28
and CD49d). Negative and positive controls were media
containing peptide vehicle (DMSO) plus costimulatory antibodies,
and staphylococcus enterotoxin B (SEB, 5 mg/ml), respectively.
The expression of CD107a, MIP-1b, IL-2, TNF-a and IFN-c
were measured using a modification of a previously described
method [26,27]. Briefly, 1610
6 cells in 200 ml complete medium
were treated with anti-CD28 (2.5 mg/ml), anti-CD49d (5 mg/ml),
anti-CD107a, monensin (1 mM GolgiStop
TM, BD Biosciences),
brefeldin A (5 mg/ml, Sigma), and HIVgag peptide pool or
DMSO. Following a 5 hour incubation, cells were incubated for
5 minutes in PBS/2% FCS/0.5 mM/EDTA, stained for surface
markers and 7-AAD (Pharmingen) in PBS/2% FCS for 20 min at
4uC, fixed in 4% formaldehyde, then permeabilized using FACS
Perm 2 (BD Biosciences). Cells were then washed in PBS/2%
FCS, stained for intracellular markers and CD3, washed again,
then stored at 4u C in PBS/1% formaldehyde until analysis (within
24 hours). Non-fluorescent Actinomycin D (2 mg/ml) was included
in reagents after the 7-AAD staining step to saturate sites that
could bind residual 7-AAD [41,42].
Phenotypic staining of unstimulated peripheral and rectal CD8+
T-cells for surface and intracellular antigens was carried out using
Caltag Fix and Perm (Invitrogen) according to the manufacturer’s
protocol. Stained cells were stored at 4u C in PBS/1%
formaldehyde until analysis (within 24 hours). Flow cytometry
gating was as shown in Fig. 1, except that the endpoint gates were
phenotypic markers rather than functional responses.
Figure 8. Phenotypic features of CD8+ T-cells from PBMC and rectal mucosa. Unstimulated cells were stained for surface markers and
intracellular antigens and analyzed by flow cytometry. The percentage of CD8+ T-cells positive for each marker is given on the Y-axis. Median values
are indicated by a horizontal line. Statistically significant differences between groups (p,0.05) are denoted by an asterisk with solid line (Kruskal-
Wallis) or broken line (Paired T-test). Rectal mucosa (filled circles); PBMC (open circles); ‘off’, not on ART; ‘on’, on ART; s/n, seronegative.
doi:10.1371/journal.pone.0003577.g008
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antigen-specific responses
Net antigen-specific responses were evaluated using a statistical
test [43] to determine whether the percent of CD8+ T-cells
responding to Gag plus costimulation differed significantly from
the percent of CD8+ T-cells responding to costimulation alone.
This step was considered critical to the analysis given the
observation that mucosal lymphocytes are partially activated in
vivo and frequently exhibit elevated cytokine production relative to
PBMC [26,34,44,45]. The statistical test was based on the
assumption of a Poisson distribution for both conditions, and
calculations utilized the number of gated fluorescence events
collected, rather than percentages. This was considered advanta-
geous given the fact that mucosal cell isolation protocols generally
yield a lower number of viable lymphocytes than PBMC isolation
protocols [40]. Within this framework, a choice of tests was made
that generally controls the significance level of the test to the
nominal level [43]. The following formula shows how the
statistical test was structured to accommodate flow cytometry
response data:
W3~
ln X1=X0 ðÞ {ln n1=n0 ðÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1=X0z1=X1
p
The value X1 is the number of cells (i.e., positive fluorescence
events) responding to peptide plus costimulation within a total
CD8+ T-cell population designated as n1. Similarly, X0 is the
number of events associated with costimulation alone within a
total CD8+ T-cell population designated as n0. The test was
carried out as follows: (1) If one or both of X0 and X1 was equal to
zero, then the value was set to 0.5; (2) the test statistic W3 was
calculated; (3) the test statistic W3 was referred to a standard
normal distribution and the p-value was calculated; (4) If the p-
value was less than the significance level (0.05), this indicated that
the background cytokine response and the Gag-stimulated
cytokine response were statistically different. In this case, the
background response was subtracted from the Gag-specific
response to yield a statistically meaningful net response. If, on
the other hand, the p-value was equal to or greater than 0.05, this
indicated that the background cytokine response and the Gag-
stimulated response were not statistically different. In this case, the
net Gag-specific response was set to zero.
Statistical comparisons between tissues and between
subjects
For comparisons of T-cell function between tissues within the
same patients, paired T-tests (two-tailed) were used. Mann
Whitney (two-tailed) tests were used to compare T-cell function
data between subjects (i.e., on vs. off ART) within a given tissue
type. Expression of phenotypic markers was compared between
tissues within the same patients using a paired T-test, and between
patient groups using a Kruskal-Wallis test followed by Dunn’s
Multiple Comparison Test. Correlations between CD8+ T-cell
response magnitudes and plasma viral load, CD4+ T-cell count
(blood) and CD4+ T-cell frequency (rectal MNC) were determined
using Spearman Correlation (GraphPad Prism, v5, Graph Pad
Software, San Diego, CA). Linear regression analysis was used to
display a best fit line to the data.
Linear mixed model analysis of cytokine responses
T-cell responses to antigenic stimulation were evaluated by
Boolean partitioning of responses into 31 distinct responding
populations [22,28]. For the purposes of linear mixed model
analysis, we defined polyfunctional cells as those capable of 3, 4, or
5 responses, as distinct from mono- or dual-function cells.
Percentage values were square root transformed for variance
stabilization. The transformed data were analyzed using a linear
mixed effect model with ART status, tissue type, and polyfunc-
tionality as fixed effects (including all interactions), with a random
effect for subject, and with unstructured correlation between the
tissue and polyfunction measures within each subject. The model
was estimated using restricted maximum likelihood, and degrees of
freedom were calculated using the Kenward and Roger adjust-
ment [46]. Post-hoc comparisons were performed using the
Tukey-Kramer adjustment for multiple comparisons. The level
of significance was set at 0.05. Model fit was assessed using
graphical analysis of residuals and the Shapiro-Wilks test for
normality. Analysis was implemented using the MIXED proce-
dure in SAS for Windows, Version 9.1.
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